NEUROONE MEDICAL TECHNOLOGIES CorpNMTC
Market cap
$35.8M
P/E ratio
| 2011/12 | 2014/12 | 2015/12 | 2016/12 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Depreciation & amortization | - | - | - | - | - | 47,609 | 80,748 | 118,620 | 199,266 | - |
| Stock-based compensation | - | - | - | - | - | - | - | - | 1 | 1 |
| Cash from operations | 32,299 | -26,173 | -45,151 | -21,106 | -5,395,957 | -3,425,302 | -8,602,826 | -7,519,534 | -12,886,874 | -11,011,840 |
| Capital expenditures | - | - | - | - | -58,352 | -122,427 | -67,079 | -275,226 | -384,117 | -120,197 |
| Cash from investing | - | - | - | - | -123,352 | -122,427 | -67,079 | -3,244,765 | 3 | -120,197 |
| Cash from financing | 46,150 | 25,853 | 46,784 | 21,106 | 6 | 7 | 12 | 12 | 7 | 7 |
| Free cash flow | - | - | - | - | ||||||
| FCF margin (%) | - | - | - | - | - | - |